A
Price
$125.60
Change
+$2.36 (+1.91%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
34.94B
77 days until earnings call
MTD
Price
$1260.32
Change
+$0.78 (+0.06%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
25.95B
52 days until earnings call
Interact to see
Advertisement

A vs MTD

Header iconA vs MTD Comparison
Open Charts A vs MTDBanner chart's image
Agilent Technologies
Price$125.60
Change+$2.36 (+1.91%)
Volume$50.05K
Capitalization34.94B
Mettler-Toledo International
Price$1260.32
Change+$0.78 (+0.06%)
Volume$495
Capitalization25.95B
A vs MTD Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. MTD commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and MTD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (A: $123.24 vs. MTD: $1259.54)
Brand notoriety: A and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 74% vs. MTD: 73%
Market capitalization -- A: $34.94B vs. MTD: $25.95B
A [@Medical Specialties] is valued at $34.94B. MTD’s [@Medical Specialties] market capitalization is $25.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while MTD’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 6 bearish.
  • MTD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MTD is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -4.28% price change this week, while MTD (@Medical Specialties) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +22.73%. For the same industry, the average monthly price growth was +27.37%, and the average quarterly price growth was +27.23%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

MTD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+22.73% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($34.9B) has a higher market cap than MTD($25.9B). MTD has higher P/E ratio than A: MTD (31.94) vs A (28.79). MTD YTD gains are higher at: 2.931 vs. A (-7.874). A has higher annual earnings (EBITDA): 1.8B vs. MTD (1.22B). A has more cash in the bank: 1.54B vs. MTD (61.8M). MTD has less debt than A: MTD (2.18B) vs A (3.41B). A has higher revenues than MTD: A (6.79B) vs MTD (3.87B).
AMTDA / MTD
Capitalization34.9B25.9B135%
EBITDA1.8B1.22B148%
Gain YTD-7.8742.931-269%
P/E Ratio28.7931.9490%
Revenue6.79B3.87B176%
Total Cash1.54B61.8M2,484%
Total Debt3.41B2.18B156%
FUNDAMENTALS RATINGS
A vs MTD: Fundamental Ratings
A
MTD
OUTLOOK RATING
1..100
8456
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
7170
SMR RATING
1..100
453
PRICE GROWTH RATING
1..100
5659
P/E GROWTH RATING
1..100
4770
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (48) in the Biotechnology industry is somewhat better than the same rating for MTD (99) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (70) in the Medical Specialties industry is in the same range as A (71) in the Biotechnology industry. This means that MTD’s stock grew similarly to A’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for A (45) in the Biotechnology industry. This means that MTD’s stock grew somewhat faster than A’s over the last 12 months.

A's Price Growth Rating (56) in the Biotechnology industry is in the same range as MTD (59) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

A's P/E Growth Rating (47) in the Biotechnology industry is in the same range as MTD (70) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMTD
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
55%
Momentum
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
52%
MACD
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 11 days ago
62%
Bullish Trend 8 days ago
62%
Declines
ODDS (%)
Bearish Trend 6 days ago
60%
Bearish Trend 6 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PLTM13.500.12
+0.90%
GraniteShares Platinum Trust
ZMAR26.990.02
+0.07%
Innovator Equity Defined Prt ETF -1YrMar
ETCG11.120.01
+0.05%
Grayscale Ethereum Classic Trust (ETC)
JUNZ32.46N/A
N/A
TrueShares Structured Outcome June ETF
BSCT18.90-0.02
-0.11%
Invesco BulletShares 2029 Corp Bd ETF